Prevention of VTE following total hip and knee arthroplasty in hemophilia patients

Orthopedics

Volumn 34, Issue 5, 2011, Pages

  Stein, Matthew I ^a   Park, Justin ^b   Raterman, Stephen ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

BLEEDING; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; HEMOPHILIA; HIP ARTHROPLASTY; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; REVIEW; THROMBOSIS PREVENTION; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM; HEMOPHILIA A; KNEE ARTHROPLASTY;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FIBRINOLYTIC AGENTS; HEMOPHILIA A; HUMANS; PLATELET AGGREGATION INHIBITORS; VENOUS THROMBOEMBOLISM;

EID: 79955826353     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20110317-21     Document Type: Review

References (32)

1. Luck JV Jr, Silva M, Rodriguez-Merchan EC, Ghalambor N, Zahiri CA, Finn RS. Hemophilic arthropathy. J Am Acad Orthop Surg. 2004; 12(4):234-245.
2. Ballal RD, Botteman MF, Foley I, Stephens JM, Wilke CT, Joshi AV. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling [published online ahead of print January 29, 2008]. Curr Med Res Opin. 2008; 24(3):753-768.
3. Miles J, Rodríguez-Merchán EC, Goddard NJ. The impact of haemophilia on the success of total hip arthroplasty [published online ahead of print November 22, 2007]. Haemophilia. 2008; 14(1):81-84.
4. Della Valle CJ, Steiger DJ, Di Cesare PE. Thromboembolism after hip and knee arthroplasty: diagnosis and treatment. J Am Acad Orthop Surg. 1998; 6(6):327-336.
5. Xing KH, Morrison G, Lim W, Douketis J, Odueyungbo A, Crowther M. Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials [published online ahead of print July 11, 2008]. Thromb Res. 2008; 123(1)24-34.
6. Cohen SH, Ehrlich GE, Kauffman MS, Cope C. Thrombophlebitis following knee surgery. J Bone Joint Surg Am. 1973; 55(1):106-112.
7. Stringer MD, Steadman CA, Hedges AR, Thomas EM, Morley TR, Kakkar VV. Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients. J Bone Joint Surg Am. 1989; 71(3):492-497. (Pubitemid 19130479)
8. Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am. 1984; 66(2):194-201. (Pubitemid 14150384)
9. Lassen MR, Borris LC, Christiansen HM, et al. Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo. Acta Orthop Scand. 1991; 62(1):33-38.
10. Turpie AG, Levine MN, Hirsh J, et al. A randomized controlled trial of low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986; 315(15):925-929. (Pubitemid 16023679)
11. Kim YH, Kim JS. Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br. 2002; 84(4):566-570.
12. Cordell-Smith JA, Williams SC, Harper WM, Gregg PJ. Lower limb arthroplasty complicated by deep venous thrombosis. Prevalence and subjective outcome. J Bone Joint Surg Br. 2004; 86(1):99-101. (Pubitemid 38128714)
13. Dargaud Y, Cruchaudet BB, Lienhart A, Coppéré B, Ninet J, Négrier C. Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A. Blood Coagul Fibrinolysis. 2003; 14(4):407-409. (Pubitemid 36688196)
14. Ettingshausen CE, Saguer IM, Kreuz W. Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding-successful thrombolysis under heparin therapy. Eur J Pediatr. 1999; 158(Suppl 3):S180-182.
15. Butcher JH, Pasi KJ. Fatal postoperative pulmonary embolism in mild haemophilia. Haemophilia. 2006; 12(2):179-182.
16. Girolami A, Scandellari R, Zanon E, Sartori R, Girolami B. Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases. J Thromb Thrombolysis. 2006; 21(3):279-284. (Pubitemid 43676787)
17. Krause M, Ch. Von Auer, Kurth A, Bohm M, Hovy L, Scharrer I. (2007). Evaluation of thrombotic events in hemophiliacs undergoing major orthopedic surgery without thrombosis prophylaxis. Presented at: the 36th Hemophilia Symposium; Hamburg, Germany; March 1-4, 2005.
18. Silva M, Luck JV Jr. Long-term results of primary total knee replacement in patients with hemophilia. J Bone Joint Surg Am. 2005; 87(1):85-91. (Pubitemid 40094142)
19. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl):381S-453S.
20. Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians Guidelines for Venous Thromboembolism Prevention in Hip and Knee Arthroplasty Differ: What are the Implications for Clinicians and Patients? Chest. 2009; 135(2):513-520.
21. Zimlich RH, Fulbright BM, Friedman RJ. Current status of anticoagulation therapy after total hip and total knee arthroplasty. J Am Acad Orthop Surg. 199; 64(2):54-62.
22. American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty. Adopted by the American Academy of Orthopedic Surgeons Board of Directors May 2007. Available at: www. aaos.org/research/guidelines/PE- guideline.pdf.
23. Callaghan JJ, Warth LC, Hoballah JJ, Liu SS, Wells CW. Evaluation of deep venous thrombosis prophylaxis in low-risk patients undergoing total knee arthroplasty. J Arthroplasty. 2008; 23(6 Suppl 1):20-24.
24. Dorr LD, Gendelman V, Maheshwari AV, Boutary M, Wan Z, Long WT. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. J Bone Joint Surg Am. 2007; 89(12):2648-2657. (Pubitemid 350230619)
25. Friedman RJ. Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty. J Am Acad Orthop Surg. 2007; 15(3):148-155.
26. Bae DK, Yoon KH, Kim HS, Song SJ. Total knee arthroplasty in hemophilic arthropathy of the knee. J Arthroplasty. 2005; 20 (5):664-668.
27. Chiang CC, Chen PQ, Shen MC, Tsai W. Total knee arthroplasty for severe haemophilic arthropathy: long-term experience in Taiwan. Haemophilia. 2008; 14(4):828-834. (Pubitemid 352016041)
28. Beeton K, Rodriguez-Merchan EC, Alltree J. Total joint arthroplasty in haemophilia. Haemophilia. 2000; 6(5):474-481.
29. Innocenti M, Civinini R, Carulli C, Villano M, Linari S, Morfini M. A modular total knee arthroplasty in haemophilic arthropathy [published online ahead of print June 29, 2007]. Knee. 2007; 14(4):264-268.
30. Rodriguez-Merchan EC. Total knee replacement in haemophilic arthropathy. J Bone Joint Surg Br. 2007; 89(2):186-188. (Pubitemid 46421463)
31. Dargaud Y, Meunier S, Negrier C. Haemophlia and thrombophilia: an unexpected association! Haemophilia. 2004; 10(4):319-326.
32. Pruthi RK, Heit JA, Green MM, et al. Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden). Haemophilia. 2000; 6(6):631-634.